Protagenic Therapeutics Files 8-K
Ticker: PTIXW · Form: 8-K · Filed: May 22, 2024 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | May 22, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
Related Tickers: PTIX
TL;DR
PTIX filed an 8-K on 5/22 for Reg FD and exhibits.
AI Summary
Protagenic Therapeutics, Inc. filed an 8-K on May 22, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Atrinsic, Inc., is incorporated in Delaware and headquartered in New York. This filing does not contain specific financial figures or material events beyond the reporting of these items.
Why It Matters
This 8-K filing indicates Protagenic Therapeutics is providing updates and financial information to the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any immediate material adverse events.
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer
- May 22, 2024 (date) — Date of Report
- Atrinsic, Inc. (company) — Former Company Name
- New York (location) — Business Address City
- Delaware (location) — State of Incorporation
FAQ
What is the primary purpose of this 8-K filing by Protagenic Therapeutics, Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.
On what date was this 8-K filing reported?
This 8-K filing was reported on May 22, 2024.
What was Protagenic Therapeutics, Inc. formerly known as?
Protagenic Therapeutics, Inc. was formerly known as Atrinsic, Inc.
In which state is Protagenic Therapeutics, Inc. incorporated?
Protagenic Therapeutics, Inc. is incorporated in Delaware.
What is the business address of Protagenic Therapeutics, Inc.?
The business address of Protagenic Therapeutics, Inc. is 149 Fifth Avenue, Suite 500, New York, NY 10010.
Filing Stats: 448 words · 2 min read · ~1 pages · Grade level 10.1 · Accepted 2024-05-22 09:15:11
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex99-1.htm (EX-99.1) — 10KB
- 0001493152-24-020973.txt ( ) — 268KB
- protageniccom-20240522.xsd (EX-101.SCH) — 4KB
- protageniccom-20240522_def.xml (EX-101.DEF) — 26KB
- protageniccom-20240522_lab.xml (EX-101.LAB) — 36KB
- protageniccom-20240522_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROTAGENIC THERAPEUTICS, INC. Date: May 22, 2024 By: /s/ Alexander K. Arrow Name: Alexander K. Arrow Title: Chief Financial Officer 3